The tumour microenvironment (TME) constitutes a highly organised system of intercellular communication, in which the transfer of information is as decisive as the genetic alterations inherent to tumour cells. In this context, exosomes have emerged as key mediators of tumour crosstalk, acting as specialised vehicles capable of transferring molecular information with a functional impact on both local and distant cells.
Exosomes are generated via the endosomal pathway, through the formation of multivesicular bodies (MVBs) and their subsequent fusion with the plasma membrane. This process, far from being constitutive, is finely regulated by ESCRT-dependent and -independent mechanisms, allowing for highly selective packaging of their contents.
As a result, the exosomal cargo —comprising proteins, lipids and various RNA species— not only reflects the pathophysiological state of the cell of origin, but also determines its ability to induce specific changes in recipient cells.
Growing evidence suggests that small variations in this cargo can translate into significant functional differences, reinforcing the need for analytical approaches capable of resolving heterogeneity at the level of vesicular subpopulations.
Exosome-mediated communication does not follow a linear model, but rather a complex and hierarchical network in which tumour cells dynamically interact with multiple components of the microenvironment.
Following their release, exosomes can be internalised by target cells via various mechanisms, triggering the reprogramming of intracellular signalling pathways. This phenomenon allows tumour cells to extend their influence beyond their immediate surroundings, actively modulating the behaviour of fibroblasts, immune cells and endothelial cells.
The precise characterisation of these interactions requires tools capable of integrating phenotypic and functional information at the single-particle level, a challenge that is still evolving in the field of extracellular vesicles.
One of the most significant effects of exosome-mediated crosstalk is the reconfiguration of the stroma. Through the transfer of bioactive factors, exosomes induce the activation of fibroblasts towards phenotypes compatible with CAFs (cancer-associated fibroblasts).
This process results in a profound remodelling of the extracellular matrix (ECM), which acquires mechanical and biochemical properties favourable to tumour progression. Tissue stiffness, the secretion of pro-inflammatory factors and the structural reorganisation of the microenvironment contribute to the establishment of a pro-tumour niche.
The functional heterogeneity of these activated fibroblasts highlights the importance of analysing not only cell populations, but also vesicular subpopulations associated with specific tumour states.
Exosomes play a decisive role in generating an immunosuppressive environment.
Through the transfer of immunoregulatory molecules and non-coding RNA, they are capable of interfering with the activation of effector cells and promoting tolerogenic phenotypes.
This mechanism contributes to the evasion of the immune response both in the local microenvironment and at the systemic level, reinforcing the relevance of exosomes as mediators of tumour immune evasion.
From an experimental perspective, the correct interpretation of these phenomena depends largely on methodologies that allow for the differentiation between vesicles with distinct biological functions within a single complex sample.
In the vascular compartment, exosomes contribute to the activation of endothelial cells, promoting angiogenesis and altering the integrity of the vascular barrier. These changes facilitate both the growth of the primary tumour and the dissemination of tumour cells into the circulation.
The ability of exosomes to induce specific endothelial responses is directly related to their molecular composition, which once again makes their detailed and reproducible characterisation in experimental and translational contexts critical.
One of the most sophisticated aspects of exosomal biology is its ability to act at a distance. Prior to the arrival of tumour cells, exosomes released by the primary tumour can condition secondary organs, modulating both resident cells and components of the extracellular matrix.
This phenomenon helps define metastatic organotropy and suggests the existence of specific exosomal signals associated with the preparation of the premetastatic niche. The detection and analysis of these signals requires sensitive approaches capable of capturing biological events at early stages.
Exosome-mediated horizontal transfer of information also plays a critical role in the acquisition and dissemination of therapeutic resistance. Through their cargo, they can modulate pathways associated with cell survival, apoptosis and drug response.
This mechanism contributes to tumour plasticity, favouring dynamic adaptation to therapeutic pressures. The identification of exosomal signatures associated with resistance is an area of growing interest in the development of patient monitoring and stratification strategies.
The potential of exosomes in clinical applications is particularly relevant in the field of liquid biopsy, where their stability in biofluids and their molecular content make them valuable sources of non-invasive biological information.
However, translating this potential into robust applications depends largely on the availability of technologies capable of addressing key challenges such as vesicle heterogeneity, precise quantification, and simultaneous multi-parameter characterisation.
In this regard, approaches based on single-particle analysis, multi-parametric phenotyping and high-sensitivity technologies are playing an increasingly important role in the functional understanding of the exosomal system.
Despite advances, the field of extracellular vesicles continues to face significant limitations. The lack of standardisation, the coexistence of multiple vesicular subpopulations, and the difficulties inherent in their isolation and analysis remain significant barriers.
These limitations highlight the need for integrated methodological approaches that allow not only the isolation, but also the characterisation and functional correlation of different exosomal populations within complex biological systems.
Exosomes represent essential functional nodes in the communication network of the tumour microenvironment, playing a central role in coordinating processes ranging from immunomodulation to metastasis.
Their study not only broadens our understanding of cancer biology but also drives the need for advanced analytical tools capable of capturing the system’s complexity. In this context, the ability to analyse extracellular vesicles with high resolution, sensitivity and reproducibility stands as a key element for progress in both basic and translational research.